ArticleMolecular and clinical oncology2019

Identification of favorable subgroups for alternative anti-androgen therapy in castration-resistant prostate cancer.

Kotaro Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.